Schroder Investment Management Group Grows Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Schroder Investment Management Group boosted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 22.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 61,727 shares of the company’s stock after buying an additional 11,460 shares during the period. Schroder Investment Management Group’s holdings in Addus HomeCare were worth $7,795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of ADUS. Quarry LP purchased a new stake in Addus HomeCare in the 3rd quarter valued at approximately $28,000. Smartleaf Asset Management LLC lifted its holdings in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after buying an additional 214 shares during the period. Parkside Financial Bank & Trust boosted its stake in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after buying an additional 148 shares in the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Addus HomeCare during the fourth quarter worth $86,000. Finally, KBC Group NV raised its position in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after acquiring an additional 268 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ADUS has been the topic of a number of recent analyst reports. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Oppenheimer lifted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. JMP Securities began coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Finally, Macquarie reaffirmed an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Trading Down 1.0 %

Shares of NASDAQ:ADUS opened at $100.31 on Friday. The firm has a market cap of $1.82 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 1.41 and a beta of 0.93. The stock’s 50-day moving average price is $105.09 and its two-hundred day moving average price is $119.69. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. As a group, research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.